RA Capital Nexus Fund II, L.P.'s Net Worth
Estimate Recalculated Jan 4, 2025 01:02AM EST
Who is RA Capital Nexus Fund II, L.P.
RA Capital Nexus Fund II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., Cytek Biosciences, Inc., DICE Therapeutics, Inc., Icosavax, Inc., Eliem Therapeutics, Inc., Acumen Pharmaceuticals, Inc., ARS Pharmaceuticals, Inc., Janux Therapeutics, Inc., PepGen Inc., Acrivon Therapeutics, Inc., LENZ Therapeutics, Inc., Boundless Bio, Inc., and Werewolf Therapeutics, Inc..
SEC CIK
RA Capital Nexus Fund II, L.P.'s CIK is 0001825376
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
